top of page
Read • watch • learn
Welcome to the Hope Bio Blog




2025 Annual Review
Happy, happy 2026, Hope community! One of our favorite parts of welcoming a new year is to reflect on the period concluding. There are many ways to present annual reviews, and in the near-decade since our founding we have tried many, from formal materials and presentations to stakeholder reports. This year, however, we’re trying something new – we want to celebrate the year with those who made it possible, in plain language. We want to celebrate with you . If you prefer t
janshultis
Jan 94 min read


On Biotech and Beryl
At Hope Biosciences, our love language is stewardship (cliché, perhaps, but true!). Some days that stewardship is grittier than others, like
Jan Shultis
Aug 8, 20244 min read


A Look Back at a Hope-filled 2023 at Hope Biosciences
Written by Jan Shultis In 2023, Texas-based biopharmaceutical company Hope Biosciences, LLC cultured approximately 170 billion adult stem cells for use in dozens of disease and injury conditions, including in 18 FDA-authorized research protocols. It was a year that saw a new volume of peer-reviewed publications, conference presentations, and community engagements. Also in 2023, Hope Biosciences increasingly became a household name in skincare, with a partner’s very public la
Hope Biosciences
Jan 16, 20246 min read
bottom of page
